Why the study?
South Asians exhibit excess cardiometabolic risk, but much remains unknown regarding the underlying contributors across individual, community, and population levels.
This clinical practice statement provides a comprehensive framework for addressing the excess cardiometabolic risk observed in South Asian populations in North America.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“South Asian (SA) individuals experience a disproportionate burden of premature atherosclerotic cardiovascular disease (ASCVD), and this excess risk is not fully explained by traditional risk factors. Standard calculators may underestimate risk in SA adults.”
Enables targeted cardiometabolic risk mitigation for South Asian patients in North America; extends general guidelines to address population-specific disparities.
South Asians (SAs) represent an increasing proportion of North American populations and demonstrate excess cardiometabolic risk. Multiple factors likely contribute; however, much is not yet known about what leads to this excess risk. Diet composition, physical activity, and mental health are important lifestyle contributors. Specific adverse pregnancy outcomes are higher in SA women and represent an early opportunity for intervention. More broadly, comprehensive assessments of adiposity, diabetes, hypertension, dyslipidemia, coronary atherosclerosis via imaging, and genetic risk may improve detection and awareness among SAs and those treating SAs. At an individual level, culturally tailored preventive clinics may foster awareness and detection, leading to improved prevention and management of cardiometabolic risk. At a community and population level, assessments of the impact of social determinants, acculturation, and the environment may lead to broader initiatives to improve health in SAs. Lastly, supporting expanded investigation, policy, and other health and science measures at an institutional and societal level may lead to broad but impactful changes across the North American diaspora. In this clinical practice statement, we aim to provide a roadmap of the path forward in each of these domains for health care providers and health systems, community outreach groups, and stakeholders invested in investigation and policy to mitigate risk and empower SAs to lead healthy lives.
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Rohatgi et al. (2025) conducted a review in Cardiometabolic risk. This clinical practice statement provides a comprehensive framework to mitigate excess cardiometabolic risk in South Asians across individual, community, and population levels.
Synapse has enriched 10 related papers. Consider them for comparative context: